Surgical site infection associated with the use of bovine serum albumine-glutaraldehyde surgical adhesive (BioGlue®) in cranial surgery: a case–control study
Authors:
- 7 October 2010
- journal article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 153 (1) , 156-163
Abstract
To enhance the water tightness of dura mater closure in cranial surgery, an organic glue called BioGlue® was used in our neurosurgical department between January 2006 and June 2007. During this period of time, we noticed an important increase in the surgical site infection (SSI) incidence. We conducted a case–control study to identify risk factors for these infections. Our objective was to test the hypothesis that BioGlue® was one of the risk factors. Cases with infection were defined retrospectively. We included two controls per case. Study data were age, sex, time of year, in stay hospital preoperative time, length of surgery, type of surgery, surgeon, use of BioGlue®, and use of duraplasty. We first performed a univariate analysis and then the significant variables were introduced in a logistic regression model. Thirty patients were defined as cases (60 controls). In multivariate analysis, risk factors were young age (p = 0.04), extended operative length (p = 0.02) and the use of BioGlue (p = 0.007). The combined use of BioGlue® and Neuropatch® appeared to be a significant risk factor for SSI (p = 0.002). BioGlue® seems to increase the risk of SSI for patients who underwent craniotomy, especially when associated with synthetic dural graft. BioGlue® triggers an intense inflammatory response, which causes wound breaches allowing bacteria to spread down in the wound, and then creates an ideal environment for bacterial growth.Keywords
This publication has 23 references indexed in Scilit:
- A comparison of a bovine albumin/glutaraldehyde glue versus fibrin sealant for hernia mesh fixation in experimental onlay and IPOM repair in ratsSurgical Endoscopy, 2010
- Natura Abhorret a Vacuo—use of fibrin glue as a filler and sealant in neurosurgical “dead spaces”. Technical noteActa Neurochirurgica, 2010
- BioGlue® for prevention of postoperative cerebrospinal fluid leaks in transsphenoidal surgery: a case seriesSurgical Neurology, 2006
- Release of Glutaraldehyde From an Albumin-Glutaraldehyde Tissue Adhesive Causes Significant In Vitro and In Vivo ToxicityThe Annals of Thoracic Surgery, 2005
- Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4578 patientsBritish Journal Of Neurosurgery, 2005
- Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxisSurgical Neurology, 2005
- Inflammatory response after bioglue applicationThe Annals of Thoracic Surgery, 2002
- Relationship between Skin Microbial Counts and Surgical Site Infection after NeurosurgeryClinical Infectious Diseases, 2001
- BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathologyThe Annals of Thoracic Surgery, 2001
- Risk Factors for Neurosurgical Site Infections after Craniotomy: A Prospective Multicenter Study of 2944 PatientsNeurosurgery, 1997